Log In
Print
BCIQ
Print
Print this Print this
 

vedolizumab (MLN0002)

  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionHumanized mAb against integrin alpha(4)beta(7)
Molecular Target Integrin alpha(4)beta(7)
Mechanism of ActionBinds integrin alpha(4)beta(7)
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today